Imaging findings in craniofacial childhood rhabdomyosarcoma

Nicole J M Freling1, Johannes H M Merks, Peerooz Saeed

  • 1Radiology Department, Academic Medical Centre, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands. n.j.freling@amc.uva.nl

Pediatric Radiology
|August 21, 2010
PubMed

Insights

Rhabdomyosarcoma (RMS) is a common childhood cancer, particularly in the head and neck. This review covers its clinical and imaging features, diagnostic considerations, and post-treatment changes.

Area of Science:

  • Pediatric oncology
  • Radiology
  • Soft-tissue sarcomas

Background:

  • Rhabdomyosarcoma (RMS) is the most frequent pediatric soft-tissue sarcoma.
  • Head and neck tumors represent 40% of all childhood RMS cases.

Purpose of the Study:

  • To review the clinical and imaging presentation of craniofacial RMS.
  • To discuss optimal imaging techniques and characteristic features.
  • To provide an overview of differential diagnoses and post-treatment changes.

Main Methods:

  • Literature review focusing on craniofacial rhabdomyosarcoma.
  • Analysis of clinical presentations and imaging findings.
  • Discussion of diagnostic imaging modalities and differential diagnoses.

Main Results:

  • Craniofacial RMS presents with specific clinical and imaging characteristics.
  • Appropriate imaging techniques are crucial for diagnosis.
  • Differential diagnosis is essential for accurate patient management.

Conclusions:

  • Understanding the imaging features of craniofacial RMS aids in early diagnosis.
  • Multimodality imaging plays a key role in evaluating these tumors.
  • Knowledge of differential diagnoses improves patient outcomes.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...